Search Results - "DSOUZA, NINOSCHKA"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    14-LB: Somatostatin Receptor 2 Antagonism Enhances Plasma Glucagon Levels during Insulin-Induced Hypoglycemia in a Rodent Model of Type 2 Diabetes Mellitus by NEJAD-MANSOURI, MEHRAN, ZAREE BAVANI, PARINAZ, AIKEN, JULIAN, DSOUZA, NINOSCHKA C., HOFFMAN, EMILY G., LIGGINS, RICHARD, RIDDELL, MICHAEL

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…Somatostatin Receptor 2 antagonists (SSTR2a) increase glucagon counter-regulation to hypoglycemia in various rodent models of type-1 diabetes mellitus. Here we…”
    Get full text
    Journal Article
  2. 2

    1778-LB: Comparing a Somatostatin Receptor 2 Antagonist (SSTR2a) to Exogenous Glucagon (EG) for the Treatment of Severe Insulin-Induced Hypoglycemia by Hoffman, Emily G, Dsouza, Ninoschka, Aleali, Nadia, Nozariasbmarz, Newsha, Fatehi, Samaneh, Shakeri, Dorsa, Chan, Owen, Liggins, Richard, Riddell, Michael C

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…Introduction & Objective: Treatment of severe hypoglycemia (SH) with EG causes hyperglucagonemia, resulting in gastrointestinal distress that limits its…”
    Get full text
    Journal Article
  3. 3

    1773-LB: Impact of SSTR2a Treatment in Hypoglycemia in Male (M) and Female (F) Rat Models of Type 2 Diabetes (T2D) by Dsouza, Ninoschka, Aleali, Nadia, Shakeri, Dorsa, Atherley, Sara C, Hoffman, Emily G, Karimi-Chahartash, Sina, Javanbakhsh, Sahel, Chan, Owen, Liggins, Richard, Riddell, Michael C

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…Introduction: A single dose of SSTR2a, ZT-01, reduces hypoglycemia exposure in diabetic rat models. However, the pharmacology of daily dosing in type 2…”
    Get full text
    Journal Article
  4. 4

    1774-LB: The Glucagon Stimulating Effect in Hypoglycemia of Somatostatin Receptor 2 Antagonist (SSTR2a) Is Maintained with Repeat Dosing by Dsouza, Ninoschka, Aleali, Nadia, Shakeri, Dorsa, Atherley, Sara C, Hoffman, Emily G, Karimi-Chahartash, Sina, Javanbakhsh, Sahel, Chan, Owen, Liggins, Richard, Riddell, Michael C

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…Introduction: A single dose of SSTR2a, ZT-01, reduces hypoglycemia exposure in diabetic rat models. However, the pharmacology of daily dosing in type 2…”
    Get full text
    Journal Article
  5. 5

    133-OR: Somatostatin Receptor Type 2 Antagonism (SSTR2a) Augments Glucagon Counterregulation and Delays Hypoglycemia Onset in Type 2 Diabetic (T2D), Sprague-Dawley Rats by HOFFMAN, EMILY G., DSOUZA, NINOSCHKA, AIKEN, JULIAN, LIGGINS, RICHARD, RIDDELL, MICHAEL

    Published in Diabetes (New York, N.Y.) (01-06-2021)
    “…Background: SSTR2a rescues glucagon counterregulation in type 1 diabetic rats. Here, we investigated its potential for resisting hypoglycemic onset in…”
    Get full text
    Journal Article
  6. 6

    9-LB: Increased Islet Expression of Somatostatin and Glucagon in Male Rats with Insulin-Dependent Type 2 Diabetes by HOFFMAN, EMILY G., ATHERLEY, SARA C., AKBARIAN, NICKY, DSOUZA, NINOSCHKA, LIGGINS, RICHARD, RIDDELL, MICHAEL

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…Background: Pancreatic islet remodelling in type 1 diabetes increases somatostatin (SST) expression, which inhibits glucagon counterregulation to hypoglycemia…”
    Get full text
    Journal Article
  7. 7